 | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C21H24N2O |
| Molar mass | 320.43 g/mol g·mol−1 |
| 3D model (JSmol) | |
| |
SDB-006 is a drug that acts as a potent agonist for the cannabinoid receptors, with an EC50 of 19 nM for human CB2 receptors, and 134 nM for human CB1 receptors.[1] It was discovered during research into the related compound SDB-001 which had been sold illicitly as "2NE1".[2]
See also
References
- ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1021/acschemneuro.5b00107, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1021/acschemneuro.5b00107instead. - ^ Template:Cite DOI